CHMP recommends novel long-acting HIV treatment
The positive opinion means HIV patients could overcome challenges of taking daily oral regimens, says ViiV Healthcare's Chief Medical Officer.
List view / Grid view
The positive opinion means HIV patients could overcome challenges of taking daily oral regimens, says ViiV Healthcare's Chief Medical Officer.
In this article, European Pharmaceutical Review’s Hannah Balfour explores some of big pharma’s latest developments in HIV treatment, with commentary from ViiV Healthcare’s Head of Research and Development, Kimberly Smith.
In this article, we summarise the trial findings for the European Medicines Agency’s 13 most transformative therapies of 2020.
Ten medicines have been recommended for marketing authorisation and 10 extensions of indication have been suggested by the EMA.